TrialDevelopmental medicine and child neurology2025

Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial.

Myrthe J Ottenhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.